| For: | Lu JP, Wang J, Wang T, Wang Y, Wu WQ, Gao L. Microvessel density of malignant and benign hepatic lesions and MRI evaluation. World J Gastroenterol 2004; 10(12): 1730-1734 [PMID: 15188495 DOI: 10.3748/wjg.v10.i12.1730] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/1730.htm |
| Number | Citing Articles |
| 1 |
Shigekazu Hidaka, Terumitsu Sawai, Toru Yasutake, Takeshi Nagayasu, Kenichirou Shibata, Hiroaki Takeshita, Takafumi Abo, Yorihisa Sumida, Toshiyuki Nakayama, Atsushi Nanashima. Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(31): 4915-4922 doi: 10.3748/wjg.14.4915
|
| 2 |
V. Laurent, S. Corby, L. Antunes, C. Barbary, S. Corby-Ciprian, E. Kermarrec, S. Béot, D. Régent. Foie et contraste des lésions focales : corrélation radio-histologique. Journal de Radiologie 2007; 88(7-8) doi: 10.1016/S0221-0363(07)89917-3
|
| 3 |
Ivan Chebib, Meer Taher Shabani-Rad, Michelle S. Chow, James Zhang, Zu-hua Gao. Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma with and without Cirrhosis. Biomarker Insights 2007; 2 doi: 10.1177/117727190700200013
|
| 4 |
C.D. Marcus, V. Ladam-Marcus, C. Cucu, O. Bouché, L. Lucas, C. Hoeffel. Imaging techniques to evaluate the response to treatment in oncology: Current standards and perspectives. Critical Reviews in Oncology/Hematology 2009; 72(3) doi: 10.1016/j.critrevonc.2008.07.012
|
| 5 |
V. Laurent, J. Mathias, P.- A. Ganne, O. Bruot, D. Regent. Approche diagnostique devant une tumeur supposée bénigne du foie. Gastroentérologie Clinique et Biologique 2008; 32(5) doi: 10.1016/j.gcb.2008.04.009
|
| 6 |
Stephen L Chan, Anthony TC Chan, Winnie Yeo. Role of α-Fetoprotein in Hepatocellular Carcinoma: Prognostication, Treatment Monitoring or Both?. Future Oncology 2009; 5(6) doi: 10.2217/fon.09.64
|
| 7 |
Maria Assunta Zocco, Antonio Gasbarrini, Maurizio Pompili, Laura Riccardi, Maria Elena Ainora, Matteo Garcovich, Davide Roccarina. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. World Journal of Hepatology 2015; 7(14): 1866-1874 doi: 10.4254/wjh.v7.i14.1866
|
| 8 |
Nola Hylton. Dynamic Contrast-Enhanced Magnetic Resonance Imaging As an Imaging Biomarker. Journal of Clinical Oncology 2006; 24(20) doi: 10.1200/JCO.2006.06.8080
|